Home
Øivind F. Grytten Torkildsen's picture

Øivind F. Grytten Torkildsen

Professor
  • E-mailOivind.Torkildsen@uib.no
  • Visitor Address
    Nevrologisk avdeling, Haukeland Universitetssykehus
  • Postal Address
    Postboks 7804
    5020 Bergen
Journal articles
  • Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve. 2019. B cell depletion in the treatment of multiple sclerosis. Expert Opinion on Biological Therapy. 19: 261-271. doi: 10.1080/14712598.2019.1568407
  • Bjørnevik, Kjetil Lauvland; Myhr, Kjell-Morten; Beiske, Antonie Giæver; Bjerve, Kristian S; Holmøy, Trygve; Hovdal, Harald Olav; Midgard, Rune; Riise, Trond; Wergeland, Stig; Torkildsen, Øivind. 2018. α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients. Multiple Sclerosis. 25: 987-993. doi: 10.1177/1352458518779925
  • Hobart, Jeremy; Bowen, Amy; Pepper, George; Crofts, Harriet; Eberhard, Lucy; Berger, Thomas; Boyko, Alexey; Boz, Cavit; Butzkueven, Helmut; Celius, Elisabeth Gulowsen; Drulovic, Jelena; Flores, José; Horáková, Dana; Lebrun-Frénay, Christine; Marrie, Ruth Ann; Overell, James; Piehl, Fredrik; Rasmussen, Peter Vestergaard; Sá, Maria José; Sîrbu, Carmen-Adella; Skromne, Eli; Torkildsen, Øivind; van Pesch, Vincent; Vollmer, Timothy; Zakaria, Magd; Ziemssen, Tjalf; Giovannoni, Gavin. 2018. International consensus on quality standards for brain health-focused care in multiple sclerosis. Multiple Sclerosis. 1-10. doi: 10.1177/1352458518809326
  • Lie, Ingrid Anne; Blomberg, Bjørn; Power, Øystein Alexander; Torkildsen, Øivind. 2018. Mann i 20-årene med svimmelhet, dobbeltsyn og perifer facialisparese. Tidsskrift for Den norske legeforening. 138. 7 pages. doi: 10.4045/tidsskr.17.0801
  • Nystad, Agnes Elisabeth; Torkildsen, Øivind; Wergeland, Stig. 2018. Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model. Journal of Neuroimmunology. 321: 61-65. doi: 10.1016/j.jneuroim.2018.05.016
  • Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve; Saltyte Benth, Jurate; Wergeland, Stig; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Sagen, Jørn V.; Torkildsen, Øivind. 2018. Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis. Journal of Neuroimmunology. 323: 73-77. doi: 10.1016/j.jneuroim.2018.07.011
  • Torkildsen, Øivind; Holmøy, Trygve; Myhr, Kjell-Morten. 2018. Severe multiple sclerosis reactivation after gonadotropin treatment. Multiple Sclerosis and Related Disorders. 22: 38-40. doi: 10.1016/j.msard.2018.02.031
  • Wergeland, Stig; Riise, Trond; Torkildsen, Øivind. 2018. Response to 'Seasonal variation of vitamin D and Epstein?Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'. European Journal of Neurology. 25: e104-e104. doi: 10.1111/ene.13719
  • Bjørnevik, Kjetil; Riise, Trond; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Dahl, Ole-Petter; Kampman, Margitta Theodora; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Torkildsen, Øivind; Vatne, Anita; Grytten, Nina. 2017. Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. Multiple Sclerosis. 23: 213-219. doi: 10.1177/1352458516646863
  • Brakedal, Brage; Flønes, Irene Hana; Reiter, Simone B. C. Frizell; Torkildsen, Øivind; Dölle, Christian; Assmus, Jörg; Haugarvoll, Kristoffer; Tzoulis, Charalampos. 2017. Glitazone use associated with reduced risk of Parkinson's disease. Movement Disorders. 32: 1594-1599. doi: 10.1002/mds.27128
  • Holmøy, Trygve; Torkildsen, Øivind. 2017. Re: Familieplanlegging, graviditet og amming ved multippel sklerose. Tidsskrift for Den norske legeforening. 137: 259-259. doi: 10.4045/tidsskr.17.0054
  • Holmøy, Trygve; Torkildsen, Øivind; Myhr, Kjell-Morten. 2017. An update on cladribine for relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy. 18: 1627-1635. doi: 10.1080/14656566.2017.1372747
  • Kroksveen, Ann Cathrine; Guldbrandsen, Astrid; Vaudel, Marc; Lereim, Ragnhild Reehorst; Barsnes, Harald; Myhr, Kjell-Morten; Torkildsen, Øivind; Berven, Frode. 2017. In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis: presenting a comprehensive picture of pathways and processes affected by multiple sclerosis. Journal of Proteome Research. 16: 179-194. doi: 10.1021/acs.jproteome.6b00659
  • Nina, Grytten; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Kampman, Margitta Theodora; Midgard, Rune; Myhr, Kjell-Morten; Riise, Trond; Torkildsen, Øivind; Aarseth, Jan Harald. 2017. Cancer risk in multiple sclerosis. Multiple Sclerosis. 23: 486-487.
  • Oveland, Eystein; Nystad, Agnes Elisabeth; Berven, Frode; Myhr, Kjell-Morten; Torkildsen, Øivind; Wergeland, Stig. 2017. 1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins. Neurochemistry International. 112: 262-277. doi: 10.1016/j.neuint.2017.08.008
  • Røsjø, Egil Rørvik; Lossius, Peter Andreas Vold; Abdelmagid, Nada; Lindstrøm, Jonas Christoffer; Kampman, Margitta Theodora; Jørgensen, Lone; Sundström, Peter; Olsson, Tomas; Steffensen, Linn Hofsøy; Torkildsen, Øivind; Holmøy, Trygve. 2017. Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. Multiple Sclerosis. 23: 395-402. doi: 10.1177/1352458516654310
  • Torkildsen, Øivind; Myhr, Kjell-Morten; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Riise, Trond; Wergeland, Stig; Bjørnevik, Kjetil Lauvland. 2017. alpha-Linolenic acid (ALA) serum levels are associated with reduced MRI activity in a prospective cohort of MS patients. Multiple Sclerosis. 23: 712-712.
  • Varhaug, Kristin Nielsen; Barro, Christian; Bjørnevik, Kjetil Lauvland; Myhr, Kjell-Morten; Torkildsen, Øivind; Wergeland, Stig; Bindoff, Laurence; Kuhle, Jens; Vedeler, Christian A. 2017. Neurofilament light chain predicts disease activity in relapsing-remitting MS. Neurology: Neuroimmunology and neuroinflammation. 5:e422: 1-8. doi: 10.1212/NXI.0000000000000422
  • Holmøy, Trygve; Esbensen, Qin Ying; Torkildsen, Øivind; Wergeland, Stig; Bjerve, Kristian S; Beiske, Antonie Giæver; Midgard, Rune; Saltyte Benth, Jurate; Hovdal, Harald Olav; Myhr, Kjell-Morten. 2016. WT1 and interferon-β–vitamin D association in MS: a longitudinal study. Acta Neurologica Scandinavica. 133: 309-312. doi: 10.1111/ane.12448
  • Holmøy, Trygve; Torkildsen, Øivind. 2016. Familieplanlegging, graviditet og amming ved multippel sklerose. Tidsskrift for Den norske legeforening. 136: 1726-1729. doi: 10.4045/tidsskr.16.0563
  • Holmøy, Trygve; Torkildsen, Øivind. 2016. Can Vitamin D reduce inflammation in relapsing-remitting multiple sclerosis? Expert Review of Neurotherapeutics. 16: 233-235. doi: 10.1586/14737175.2016.1146134
  • Kvistad, Christopher Elnan; Torkildsen, Øivind; Næss, Halvor; Svalestad, Sigurd. 2016. Trombolytisk behandling og trombektomi ved ukjent slagdebut. Tidsskrift for Den norske legeforening. 136: 1363-1363. doi: 10.4045/tidsskr.16.0269
  • Kvistad, Silje; Myhr, Kjell-Morten; Holmøy, Trygve; Saltyte Benth, Jurate; Løken-Amsrud, Kristin Ingeleiv; Wergeland, Stig; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Bakke, Søren Jacob; Torkildsen, Øivind. 2016. No association of tobacco use and disease activity in multiple sclerosis. Neurology: Neuroimmunology and neuroinflammation. 3. 5 pages. doi: 10.1212/NXI.0000000000000260
  • Lereim, Ragnhild Reehorst; Oveland, Eystein; Xiao, Y.; Torkildsen, Øivind; Wergeland, Stig; Myhr, Kjell-Morten; Sun, Shao-Cong; Berven, Frode. 2016. The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis. Journal of Proteomics & Bioinformatics. doi: 10.4172/jpb.1000408
  • Lunde, Hanne Marie; Torkildsen, Øivind; Bø, Lars; Kjørsvik, Anne. 2016. Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia. Headache. 56: 1035-1039. doi: 10.1111/head.12791
  • Opsahl, Jill Anette; Vaudel, Marc; Guldbrandsen, Astrid; Aasebø, Elise; Van Pesch, Vincent; Franciotta, Diego; Myhr, Kjell-Morten; Barsnes, Harald; Berle, Magnus Foldal; Torkildsen, Øivind; Kroksveen, Ann Cathrine; Berven, Frode. 2016. Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics. 16: 1154-1165. doi: 10.1002/pmic.201500284
  • Torkildsen, Øivind; Myhr, Kjell-Morten; Bø, Lars. 2016. Disease-modifying treatments for multiple sclerosis – a review of approved medications. European Journal of Neurology. 23: 18-27. doi: 10.1111/ene.12883
  • Torkildsen, Øivind; Power, Øystein Alexander; Storstein, Anette. 2016. Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis. BMJ Case Reports. 2016:214555. doi: 10.1136/bcr-2016-214555
  • Wergeland, Stig; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Stokke, Silje Agnethe; Holmøy, Trygve; Riise, Trond; Torkildsen, Øivind. 2016. Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients. European Journal of Neurology. 23: 1064-1070. doi: 10.1111/ene.12986
  • Alme, Maria Nordheim; Nystad, Agnes Elisabeth; Bø, Lars; Myhr, Kjell-Morten; Vedeler, Christian A.; Wergeland, Stig; Torkildsen, Øivind. 2015. Fingolimod does not enhance cerebellar remyelination in the cuprizone model. Journal of Neuroimmunology. 285: 180-186. doi: 10.1016/j.jneuroim.2015.06.006
  • Fjær, Sveinung; Bø, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind; Wergeland, Stig. 2015. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochemistry International. 83-84: 28-40. doi: 10.1016/j.neuint.2015.02.006
  • Grytten, Nina; Torkildsen, Øivind; Myhr, Kjell-Morten. 2015. Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'. Acta Neurologica Scandinavica. 132: 368-369. doi: 10.1111/ane.12488
  • Grytten, Nina; Torkildsen, Øivind; Myhr, Kjell-Morten. 2015. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurologica Scandinavica. 132: 29-36. doi: 10.1111/ane.12428
  • Kroksveen, Ann Cathrine; Jaffe, Jacob D.; Aasebø, Elise; Barsnes, Harald; Bjørlykke, Yngvild; Franciotta, Diego; Keshishian, Hasmik; Myhr, Kjell-Morten; Opsahl, Jill Anette; van Pesch, Vincent; Teunissen, Charlotte E.; Torkildsen, Øivind; Ulvik, Rune Johan; Vethne, Heidrun; Carr, Steven A.; Berven, Frode. 2015. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 15: 3361-3369. doi: 10.1002/pmic.201400142
  • Kroksveen, Ann Cathrine; Opsahl, Jill Anette; Guldbrandsen, Astrid; Myhr, Kjell-Morten; Oveland, Eystein; Torkildsen, Øivind; Berven, Frode. 2015. Cerebrospinal fluid proteomics in multiple sclerosis. Biochimica et Biophysica Acta - Proteins and Proteomics. 1854: 746-756. doi: 10.1016/j.bbapap.2014.12.013
  • Kuhle, Jens; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Dalla Costa, G; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; Dalfonso, S; Alvarez-Cermeno, JC; Kleinova, P; Horakova, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, Stig; Laroni, A; Annibali, V; Romano, S; Martinez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Øivind; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, RLP; Yaldizli, O; Vecsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdova, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintore, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, Giovanni. 2015. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study. Multiple Sclerosis. 21: 1013-1024. doi: 10.1177/1352458514568827
  • Løken-Amsrud, Kristin Ingeleiv; Lossius, Peter Andreas Vold; Torkildsen, Øivind; Holmøy, Trygve. 2015. Miljøets betydning ved multippel sklerose. Tidsskrift for Den norske legeforening. 135: 856-860. doi: 10.4045/tidsskr.14.0751
  • Myhr, Kjell-Morten; Grytten, Nina; Torkildsen, Øivind; Wergeland, Stig; Bø, Lars; Aarseth, Jan Harald. 2015. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurologica Scandinavica. 132: 24-28. doi: 10.1111/ane.12427
  • Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn G.; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Holmøy, Trygve. 2015. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 280: 21-28. doi: 10.1016/j.jneuroim.2015.02.001
  • Røsjø, Egil Rørvik; Steffensen, Linn Hofsøy; Jørgensen, Lone; Lindstrøm, Jonas Christoffer; Saltyte Benth, Jurate; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Kampman, Margitta Theodora; Torkildsen, Øivind; Holmøy, Trygve. 2015. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. Journal of Neurology. 262: 2713-2721. Published 2015-12-01. doi: 10.1007/s00415-015-7902-5
  • Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve; Saltyte Benth, Jurate; Wergeland, Stig; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Bakke, Søren Jacob; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Sagen, Jørn V.; Torkildsen, Øivind. 2015. Body mass index influence interferon-beta treatment response in multiple sclerosis. Journal of Neuroimmunology. 288: 92-97. doi: 10.1016/j.jneuroim.2015.09.008
  • Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Kampman, Margitta Theodora; Torkildsen, Øivind; Myhr, Kjell-Morten. 2014. Re: Vitamin D-how much is enough, and is more better for your Health? Tidsskrift for Den norske legeforening. 134: 1024-1025. doi: 10.4045/tidsskr.14.0618
  • Nystad, Agnes Elisabeth; Wergeland, Stig; Aksnes, Lage; Myhr, Kjell-Morten; Bø, Lars; Torkildsen, Øivind. 2014. Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS : Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum. 122: 1178-1186. doi: 10.1111/apm.12281
  • Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Holmøy, Trygve. 2014. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Journal of Neuroimmunology. 271: 60-65. doi: 10.1016/j.jneuroim.2014.03.014
  • Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Løken-Amsrud, Kristin Ingeleiv; Lilleås, Finn; Midgard, Rune; Njølstad, Gro; Pedersen, Tom; Saltyte Benth, Jurate; Wergeland, Stig; Torkildsen, Øivind Fredvik. 2014. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Multiple Sclerosis. 20: 1833-1840. doi: 10.1177/1352458514533843
  • Torkildsen, Øivind Fredvik; Aarseth, Jan Harald; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Holmøy, Trygve; Kampman, Margitta Theodora; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Riise, Trond; Grytten, Nina Agnethe. 2014. Month of birth and risk of multiple sclerosis: confounding and adjustments. Annals of clinical and translational neurology. 1: 141-144. doi: 10.1002/acn3.37
  • Torkildsen, Øivind; Aarseth, Jan Harald; Celius, Elisabeth Gulowsen; Holmøy, Trygve; Kampman, Margitta Theodora; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Riise, Trond; Grytten, Nina Agnethe. 2014. Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments. Annals of clinical and translational neurology. 5: 376-377. doi: 10.1002/acn3.56
  • Torkildsen, Øivind; Myhr, Kjell-Morten; Wergeland, Stig. 2014. Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Neurology: Neuroimmunology and neuroinflammation. 1. doi: 10.1212/NXI.0000000000000025
  • Ban, Maria; Caillier, Stacy; Mero, Inger-Lise; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Aarseth, Jan Harald; Torkildsen, Øivind; Harbo, Hanne Flinstad; Oksenberg, Jorge; Hauser, Stephen L; Sawcer, Stephen; Compston, Alastair. 2013. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Annals of Neurology. 73: 430-432. doi: 10.1002/ana.23833
  • Fjær, Sveinung; Bø, Lars; Lundervold, Arvid; Myhr, Kjell-Morten; Pavlin, Tina; Torkildsen, Øivind; Wergeland, Stig. 2013. Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model. PLoS ONE. 8. doi: 10.1371/journal.pone.0084162
  • Grytten, Nina Agnethe; Torkildsen, Øivind; Aarseth, Jan Harald; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Dahl, Ole-Petter; Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Risberg, Geir; Vatne, Anita; Kampman, Margitta Theodora. 2013. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Multiple Sclerosis. 19: 1028-1034. doi: 10.1177/1352458512471094
  • Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Myhr, Kjell-Morten; Michelsen, Annika; Aukrust, Pål; Ueland, Thor. 2013. Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. PLoS ONE. 8. 9 pages. doi: 10.1371/journal.pone.0075021
  • Kampman, Margitta Theodora; Aarseth, Jan Harald; Grytten, Nina Agnethe; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Dahl, Ole-Petter; Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Risberg, Geir; Vatne, Anita; Torkildsen, Øivind. 2013. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. Journal of Neurology. 260: 1481-1488. doi: 10.1007/s00415-012-6814-x
  • Kvistad, SS; Myhr, Kjell-Morten; Holmøy, Trygve; Bakke, S.; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjornara, BT; Hovdal, Harald Olav; Loken, KI; Lilleås, F; Midgard, Rune; Njølstad, Gro; Pedersen, T; Benth, JS; Wergeland, Stig; Torkildsen, Øivind. 2013. Antibodies to Epstein-Barr virus and disease activity in multiple sclerosis. Multiple Sclerosis. 19: 400-400.
  • Løken, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Holmøy, Trygve. 2013. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Multiple Sclerosis. 19: 451-457. doi: 10.1177/1352458512457843
  • Løken-Amsrud, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Holmøy, Trygve. 2013. Alpha-tocopherol and MRI outcomes in multiple sclerosis - association and prediction. PLoS ONE. 8. 5 pages. Published 2013-01-22. doi: 10.1371/journal.pone.0054417
  • Stokke, Silje Agnethe; Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Vedeler, Christian A. 2013. Neuromyelitis optica. Tidsskrift for Den norske legeforening. 19: 2057-2061. doi: 10.4045/tidsskr.13.0608
  • Torkildsen, Øivind; Løken-Amsrud, Kristin Ingeleiv; Wergeland, Stig; Myhr, Kjell-Morten; Holmøy, Trygve. 2013. Fat-soluble vitamins as disease modulators in multiple sclerosis. Acta Neurologica Scandinavica. 127: 16-23. doi: 10.1111/ane.12045
  • Xiao, Yichuan; Jin, Jin; Chang, Mikyoung; Chang, Jae-Hoon; Hu, Hongbo; Zhou, Xiaofei; Brittain, George C.; Stansberg, Christine; Torkildsen, Øivind; Wang, Xiaodong; Brink, Robert; Cheng, Xuehong; Sun, Shao-Cong. 2013. Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nature Medicine. 19: 595-602. doi: 10.1038/nm.3111
  • Gavasso, Sonia; Torkildsen, Øivind; Marøy, Tove Helene; Ulvestad, Elling; Myhr, Kjell-Morten; Vedeler, Christian A. 2012. Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurologica Scandinavica, Supplementum. 126: 84-89. doi: 10.1111/ane.12026
  • Holmøy, Trygve; Torkildsen, Øivind; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv. 2012. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. Acta Neurologica Scandinavica. 126: 63-69. doi: 10.1111/ane.12028
  • Løken-Amsrud, Kristin Ingeleiv; Holmøy, Trygve; Bakke, Søren J.; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Sandvik, Leiv; Torkildsen, Øivind; Wergeland, Stig; Myhr, Kjell-Morten. 2012. Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment. Neurology. 79: 267-273. doi: 10.1212/WNL.0b013e31825fdf01
  • Myhr, Kjell-Morten; Grytten, Nina Agnethe; Torkildsen, Øivind; Wergeland, Stig; Bø, Lars; Pugliatti, M; Aarseth, Jan Harald. 2012. A need for national registries and international collaborative research in multiple sclerosis. Acta Neurologica Scandinavica. 126: 1-3. doi: 10.1111/ane.12039
  • Torkildsen, Øivind; Grytten, Nina Agnethe; Aarseth, Jan Harald; Myhr, Kjell-Morten; Kampman, Margitta Theodora. 2012. Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurologica Scandinavica. 126: 58-62. doi: 10.1111/ane.12040
  • Torkildsen, Øivind; Wergeland, Stig; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Lilleås, Finn; Pedersen, Tom; Bjørnarå, Bård T.; Dalene, Frøydis Christiane Moan; Kleveland, Grethe; Schepel, Jan; Olsen, Inge Christoffer; Myhr, Kjell-Morten. 2012. ω-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomised, double blind, placebo-controlled trial. Archives of Neurology. 69: 1044-1051. doi: 10.1001/archneurol.2012.283
  • Vold, Lossius Peter Andreas; Johansen, Jorunn; Torkildsen, Øivind; Vartdal, Frode; Holmøy, Trygve. 2012. Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation. Viruses. 4: 3701-3730. doi: 10.3390/v4123701
  • Wergeland, Stig; Torkildsen, Øivind; Bø, Lars; Myhr, Kjell-Morten. 2012. Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurologica Scandinavica. 126: 70-75. doi: 10.1111/ane.12034
  • Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Mørk, Sverre; Bø, Lars. 2012. The cuprizone model: regional heterogeneity of pathology. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 120: 648-657. doi: 10.1111/j.1600-0463.2012.02882.x
  • Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Aksnes, Lage; Mørk, Sverre; Bø, Lars. 2011. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS ONE. 6. 8 pages. doi: 10.1371/journal.pone.0026262
  • Ramagopalan, Sreeram V; Hanwell, Heather EC; Giovannoni, Gavin; Knappskog, Per Morten; Nyland, Harald Inge; Myhr, Kjell-Morten; Ebers, Georg C; Torkildsen, Øivind Fredvik. 2010. Vitamin D-Dependent Rickets, HIA-DRB1, and the Risk of Multiple Sclerosis. Archives of Neurology. 67: 1034-1035.
  • Torkildsen, Øivind Fredvik; Stansberg, Christine; Angelskår, Solveig Mjelstad; Kooi, Evert-Jan; Geurts, Jeroen J.G.; van der Valk, Paul; Myhr, Kjell-Morten; Steen, Vidar Martin; Bø, Lars. 2010. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathology. 20: 720-729. doi: 10.1111/j.1750-3639.2009.00343.x
  • Stansberg, Christine; Angelska, S; Kooi, Evert-Jan; Geurts, J; van der Valk, Paul; Myhr, Kjell-Morten; Steen, V; Bo, L; Torkildsen, Øivind Fredvik. 2009. Massive up-regulation of immunoglobulin-related genes in the meninges of multiple sclerosis patients without evidence for Epstein-Barr virus infection. Multiple Sclerosis. 15: S5-S5.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Milde, Anne Marita; Mørk, Sverre; Myhr, Kjell-Morten; Bø, Lars. 2009. A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. Clinical Nutrition. 28: 83-87. doi: 10.1016/j.clnu.2008.10.015
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Thorsen, Frits Alan; Mørk, Sverre; Stangel, Martin; Myhr, Kjell-Morten; Bø, Lars. 2009. Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Experimental Neurology. 215: 160-166. doi: 10.1016/j.expneurol.2008.09.026
  • Wergeland, Stig; Torkildsen, Øivind Fredvik; Myhr, Kjell-Morten; Mørk, Sverre; Bø, Lars. 2009. Histopathological characterisation of the cuprizone model for demyelination. Multiple Sclerosis. 15: S177-S177.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Milde, Anne Marita; Myhr, Kjell-Morten; Bø, Lars. 2008. Fish diet prevents impaired mobility in the murine cuprizone model for multiple sclerosis. Multiple Sclerosis. 14: S90-S91. doi: 10.1177/1352458508096399
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Myhr, Kjell-Morten; Bø, Lars. 2008. The cuprizone model for demyelination. Acta Neurologica Scandinavica. 117: 72-76. doi: 10.1111/j.1600-0404.2008.01036.x
  • Torkildsen, Øivind Fredvik; Knappskog, Per; Nyland, Harald Inge; Myhr, Kjell-Morten. 2008. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archives of Neurology. 65: 809-811.
  • Torkildsen, Øivind Fredvik; Nyland, Harald Inge; Myrmel, Helge; Myhr, Kjell-Morten. 2008. Epstein-Barr virus reactivation and multiple sclerosis. European Journal of Neurology. 15: 106-108. doi: 10.1111/j.1468-1331.2007.02009.x
  • Grytten, Nina Agnethe; Torkildsen, Øivind Fredvik; Aarseth, Jan Harald; Nyland, Harald Inge; Aarsland, Dag; Myhr, Kjell-Morten. 2007. Increasing prevalence of multiple sclerosis in the elderly in western Norway. Multiple Sclerosis. 13: S96-S96. doi: 10.1177/1352458507083605
  • Torkildsen, Øivind Fredvik; Grytten, Nina Agnethe; Myhr, Kjell-Morten. 2007. Immunomodulatory treatment of multiple sclerosis in Norway. Acta Neurologica Scandinavica. 115: 46-50. doi: 10.1111/j.1600-0404.2007.00846.x
  • Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Nyland, Harald Inge; Myhr, Kjell-Morten. 2006. Fc gamma R and multiple sclerosis: an overview. Acta Neurologica Scandinavica. 113: 61-63. doi: Se sammendrag
  • Torkildsen, O; Torkildsen, Øivind Fredvik; Utsi, Egil; Harbo, Hanne F; Mellgren, Svein Ivar; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population. Scandinavian Journal of Immunology. 62: 71-74.
  • Torkildsen, O; Torkildsen, Øivind Fredvik; Utsi, Egil; Mellgren, Svein Ivar; Harbo, Hanne F; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology. 115: 416-421.
  • Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Ulvestad, Elling; Aarseth, Jan Harald; Nyland, Harald Inge; Myhr, Kjell-Morten. 2005. High dose methylprednisolone induces FcgammaR1 on granulocytes in MS-patients. Journal of Neuroimmunology. 167: 138-142. doi: 10.1016/j.jneuroim.2005.06.009
  • Torkildsen, Øivind; Farbu, Elisabeth. 2005. Lars Hertervig og Carl Fredrik Hill - kreativitet og psykisk sykdom. Tidsskrift for Den norske legeforening. 125: 3450-3453.
Reports and theses
  • Torkildsen, Øivind Fredvik. 2010. Environmental risk factors for multiple sclerosis : results from animal and human studies on diet, vitamin D and Epstein-Barr virus.
Book sections
  • Myhr, Kjell-Morten; Torkildsen, Øivind; Bø, Lars. 2014. Multippel Sklerose. -, pages 531-540. In:
    • Gjerstad, Leif; Helseth, Eirik; Rootwelt, Terje. 2014. Nevrologi og nevrokirurgi fra barn til voksen, 6.utgave. Forlaget Vett & Viten AS. 719 pages. ISBN: 978-82-412-0709-9.

More information in national current research information system (CRIStin)